DHA SBIR SEQUENTIAL PHASE II, PROPOSAL NO. H2S-0071, TITLED: "DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE."

Source: USASpending · CONT_AWD_HT942525C0002_9700_-NONE-_-NONE- · As of 2026-06-02 · Last synced 2026-11-10

Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.

source record id

CONT_AWD_HT942525C0002_9700_-NONE-_-NONE-

generated unique award id

CONT_AWD_HT942525C0002_9700_-NONE-_-NONE-

source

USASpending

award id piid

HT942525C0002

vendor name as awarded

ALTRAZEAL LIFE SCIENCES INC

vendor uei

N24WUMUHT5V9

agency name

Department of Defense

sub agency

Defense Health Agency

contract title or description

DHA SBIR SEQUENTIAL PHASE II, PROPOSAL NO. H2S-0071, TITLED: "DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE."

naics code

541715

naics description

RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

psc code

AN12

texas nigp code

Not published

value obligated

1300000

Total / ceiling as published (not obligated)

Not published

pop start date

2025-02-07T06:00:00.000Z

expiry date

2027-06-06T05:00:00.000Z

place of performance state

TX

recipient location state

TX

set aside type

SMALL BUSINESS SET ASIDE - TOTAL

source as of

2026-06-02T05:00:00.000Z

last synced

2026-11-10T06:00:00.000Z

published

true

Source expiry field

Period of performance current end date (USASpending)